Source: Annual Congress 2010 - Tuberculosis: metabolic insights
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
R. Lungu, A. Croitoru, D. Bumbacea (Bucharest, Romania). Latent TB screening before anti-TNFα treatment. Eur Respir J 2010; 36: Suppl. 54, 3046

Member's Comments

No comment yet.

Related content which might interest you: Latent tuberculosis: diagnostic and treatment Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment Year: 2008 Latent tuberculosis infection in a drug treatment centre Source: Eur Respir J 2002; 20: Suppl. 38, 366s Year: 2002 New-immigrant screening for latent tuberculosis infection: Reasons for non-treatment Source: Annual Congress 2013 –Epidemiological and public health features of tuberculosis Year: 2013 Latent tuberculosis infection prevalence and risk of developing active TB among patients eligible for starting anti-TNFα therapy Source: International Congress 2015 – Screening strategies in TB Year: 2015 Cost-effectiveness of two latent tuberculosis infection screening strategies Source: International Congress 2018 – Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity Year: 2018 Introduction of a Latent TB infection (LTBI) screening programme detects cases of active tuberculosis and hepatitis B and C Source: International Congress 2018 – Tuberculosis transmission and screening strategies Year: 2018 A novel nurse-led approach improves treatment completion rates for latent tuberculosis infection (LTBI) treatment Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches Year: 2014 Treatment of latent infection with Mycobacterium tuberculosis: update 2010 Source: Eur Respir J 2011; 37: 690-711 Year: 2011 Latent TB infection in health care TB workers Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014 Diagnosis and treatment of latent tuberculosis infection Source: Eur Respir Monogr 2018; 82: 381-398 Year: 2018 Diagnosing and treatment of latent tuberculosis infction in children Source: Annual Congress 2009 - Tuberculosis contact screening Year: 2009 Prevalence and treatment outcome of drug resistant pulmonary tuberculosis in HIV negative cases – experience from a tuberculosis treatment center in India Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis Year: 2009 Gene-Xpert for rapid detection of MDR-TB in re-treatment cases;a comparison with standard culture and DST Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 Evaluation of a tuberculosis control programme based on case-finding Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I Year: 2013 Use of molecular-genetic methods in diagnostics and therapy of a tuberculosis (TB) at patients with HIV Source: Annual Congress 2010 - Tuberculosis in special populations Year: 2010 Influence of early diagnostics with Xpert MTB/RIF on MDR TB patients treatment efficacy Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 Anti-TNF-alpha therapy in patients with latent tuberculosis incidence Source: International Congress 2015 – Screening strategies in TB Year: 2015 Characteristics of the new cases of the tuberculosis according to the method of screening Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II Year: 2013 Risk of developing active TB in children with latent TB infection Source: International Congress 2015 – Screening strategies in TB Year: 2015